Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019

SELL
$9.1 - $15.55 $149,540 - $255,533
-16,433 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$12.5 - $18.48 $19,537 - $28,884
1,563 Added 10.51%
16,433 $228,000
Q4 2018

Jan 23, 2019

SELL
$15.25 - $22.4 $11,407 - $16,755
-748 Reduced 4.79%
14,870 $235,000
Q3 2018

Oct 25, 2018

BUY
$6.45 - $21.6 $100,736 - $337,348
15,618 New
15,618 $302,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $188M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.